Literature DB >> 2779593

The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?

W Löscher1, J E Fisher, D Schmidt, G Fredow, D Hönack, W B Iturrian.   

Abstract

Attacks of sustained dystonic postures of limbs and trunk can be initiated by mild environmental stimuli in an inbred line of Syrian hamsters. The trait is determined by an autosomal simple recessive genetic mutation, originally designated by the gene symbol sz, because the abnormal movements were thought to represent epileptic seizures. The attacks, which can be reproducibly initiated by placing the sz mutant hamsters in a new environment, begin with rapid twitches of the vibrissae, flattened ears, and flattened posture of the trunk while walking, followed by facial contortions, rearing, and sustained posturing of trunk and limbs, often resulting in falling over to the side or backwards. In the final stage, the hamsters became immobile, which can last for hours. An increased tone of limbs and trunk muscles can be palpated during the attack. Electromyographical recordings in awake, unrestrained mutant hamsters showed that the onset of the attack coincided with continuous tonic muscle activity and phasic bursts, which were present even when the animals did not move. During the attack, the animals continue to react to external stimuli. Bilateral electroencephalographic (EEG) recordings before and during motor disturbances in sz mutant hamsters showed no abnormalities. The severity of the dystonic syndrome in hamsters is age dependent with a peak at about 30-40 days of age. A score system for grading type and severity of dystonic attack was developed for use in drug activity studies. The severity of the attack was reduced or attacks were completely prevented by diazepam (1-2.5 mg/kg i.p.) and valproic acid (100-400 mg/kg i.p.) in a dose-dependent fashion. The latency to dystonic movements was significantly increased by diazepam but markedly reduced by subconvulsive doses of pentylenetetrazol (40 mg/kg s.c.). Diazepam antagonized the latency-reducing action of pentylenetetrazol in the hamsters. The pathophysiology and pharmacological sensitivity of the dystonic attacks in these animals remain to be further clarified, but the data indicate that the sz mutant hamsters might represent an interesting genetic model for paroxysmal dystonia. In view of these data, we propose that the hamster mutation should be re-named dystonic and that the new gene symbol should be designated dtsz.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779593     DOI: 10.1002/mds.870040304

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 2.  Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.

Authors:  R D Todd; J S Perlmutter
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

3.  Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.

Authors:  M Gernert; M Hamann; M Bennay; W Löscher; A Richter
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 4.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

5.  Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.

Authors:  Paul S A Kalanithi; Wei Zheng; Yuko Kataoka; Marian DiFiglia; Heidi Grantz; Clifford B Saper; Michael L Schwartz; James F Leckman; Flora M Vaccarino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

6.  Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.

Authors:  A Richter; P A Löschmann; W Löscher
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

7.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

8.  Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.

Authors:  A Richter; M Hamann
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

9.  Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia.

Authors:  Manuela Gernert; Mustapha Bennay; Maren Fedrowitz; Jan H Rehders; Angelika Richter
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  Kinematic and electromyographic tools for characterizing movement disorders in mice.

Authors:  Hans C Scholle; H A Jinnah; Dirk Arnold; Frank H W Biedermann; Bernd Faenger; Roland Grassme; Ellen J Hess; Nikolaus P Schumann
Journal:  Mov Disord       Date:  2010-02-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.